Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Escherichia coli primase (DnaG) allosteric magnesium-binding site is a critical regulatory region within the essential bacterial enzyme responsible for synthesizing RNA primers during DNA replication (Griep and Lokey, 1995). DnaG is a DNA-dependent RNA polymerase that functions as a molecular brake to coordinate the activities of the replisome on the leading and lagging strands. The enzyme contains a conserved TOPRIM domain, which includes a cluster of acidic residues that coordinate magnesium ions (Mg2+) essential for catalytic activity (CDD:240127). Biochemical studies have shown that DnaG binds at least two magnesium ions in a cooperative manner, where an allosteric magnesium-binding site induces a conformational change necessary for the enzyme to transition into its high-affinity, catalytically active state (Griep and Lokey, 1995). This site is a target for several small-molecule inhibitors, including the natural product SCH 642305 and various polyphenols, which disrupt the enzyme's function and halt bacterial proliferation (Chu et al., 2003; MDPI Molecules, 2018). Because the structure of bacterial DnaG is distinct from the human primase complex, this allosteric site represents a promising target for the development of selective, narrow-spectrum antibiotics to combat E. coli infections.
Allosteric inhibition of RNA primer synthesis by preventing the cooperative binding of magnesium ions and the subsequent conformational activation of the DnaG enzyme.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli DNA primase allosteric magnesium-binding site (DnaG allosteric Mg site).